Tiamarie Stevenson
Family · Huntsville, ALNPI 1811693435
Payments from drug & device makers
Across 115 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$710
- Merck$516
- Sanofi-aventis U.S. LLC$135
- E.r. Squibb & Sons, L.L.C.$123
- Novartis$108
- Irhythm Technologies, Inc.$103
- plus $413 from 11 others
What the payments were for
- Food & beverage$2,108100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 50 | $710 |
| Merck | 22 | $516 |
| Sanofi-aventis U.S. LLC | 8 | $135 |
| E.r. Squibb & Sons, L.L.C. | 6 | $123 |
| Novartis | 5 | $108 |
| Irhythm Technologies, Inc. | 3 | $103 |
| Boston Scientific | 3 | $63 |
| Lexicon Pharmaceuticals, Inc. | 3 | $58 |
| Pfizer | 3 | $56 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $55 |
| AstraZeneca | 3 | $43 |
| Edwards Lifesciences | 1 | $37 |
| Lilly USA, LLC | 2 | $34 |
| Philips North America LLC | 1 | $20 |
| Amgen | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $10 |
How this compares
$2,108 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 49 | $58,101 |
| XareltoRivaroxaban | 52 | $49,689 |
| EntrestoSacubitril/Valsartan | 26 | $27,200 |
| BrilintaTicagrelor | 16 | $11,780 |
| Clonidine | 16 | $2,130 |
| Flecainide Acetate | 39 | $2,118 |
| Metoprolol Succinate | 137 | $1,950 |
| Prasugrel Hcl | 17 | $1,004 |
| Atorvastatin Calcium | 59 | $984 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 18 | $761 |
| Chlorthalidone | 40 | $760 |
| Potassium Chloride | 15 | $715 |
| Nebivolol Hcl | 12 | $555 |
| Amiodarone Hcl | 15 | $490 |
| Losartan Potassium | 44 | $481 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $56 | $58,10149 claims |
| NovartisEntresto | $108 | $27,20026 claims |
| AstraZenecaBrilinta | $43 | $11,78016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,415 family providers in Alabama.
Other family in Huntsville
- Leigh Ann ChildressHuntsville$240K
- Christina CanteyHuntsville$118K
- Julia BettsHuntsville$27K
- Joann IkardHuntsville$19K
- Hannah GarnettHuntsville$18K
- Alyssa FikesHuntsville$15K
- Justin WilsonCullman$1.1M
- Molly ReevesAuburn$158K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.